Disclosed herein are the compounds: N-(4-{ 4-amino-7-[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]thieno[3,2-c]pyridin-3-yl} phenyl)-N -(3-fluorophenyl)urea； N-(4-{ 4-amino-7-[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]thieno[3,2-c]pyridin-3-yl} phenyl)-N'-[4-(difluoromethoxy)phenyl]urea； N-[4-(4-amino-7-{ 1-[(2S)-2-hydroxypropyl]-1H-pyrazol-4-yl} thieno[3,2-c]pyridin-3-yl)phenyl]N'-(3-methylphenyl)urea； N-(4-{ 4-amino-7-[1-(2-hydroxy-2-methylpropyl)-1H-pyrazol-4-yl]thieno[3,2-c]pyridin-3-yl} phenyl)-N'-(4-methoxyphenyl)urea； and N-[4-(4-amino-7-{ 1-[(2S)-2,3-dihydroxypropyl]-1H-pyrazol-4-yl} thieno[3,2-c]pyridin-3-yl)phenyl]-N'-(4-methoxyphenyl)urea. Said compounds are useful as kinase inhibitors and as such is useful in the treatment of cancer.
